info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142756 |
| CAS No | NA |
| Mol.F. | C12H10N2O5S |
| Mol.Wt. | 294.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142757 |
| CAS No | NA |
| Mol.F. | C18H18N2O3 |
| Mol.Wt. | 310.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142758 |
| CAS No | NA |
| Mol.F. | C18H19N3O2 |
| Mol.Wt. | 309.37 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142759 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142760 |
| CAS No | NA |
| Mol.F. | C28H29N3O3 |
| Mol.Wt. | 455.56 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142761 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142762 |
| CAS No | NA |
| Mol.F. | C47H49N5O4 |
| Mol.Wt. | 747.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142763 |
| CAS No | 68962-15-2 |
| Mol.F. | C12H9ClN2O |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142764 |
| CAS No | NA |
| Mol.F. | C13H8Cl2N2O3 |
| Mol.Wt. | 311.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142765 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O3 |
| Mol.Wt. | 325.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142766 |
| CAS No | NA |
| Mol.F. | C8H6N2O2 |
| Mol.Wt. | 162.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142767 |
| CAS No | NA |
| Mol.F. | C14H9Cl3N2O2 |
| Mol.Wt. | 343.59 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142768 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142769 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O3 |
| Mol.Wt. | 367.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142770 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O4 |
| Mol.Wt. | 339.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142771 |
| CAS No | NA |
| Mol.F. | C14H10BrClN203 |
| Mol.Wt. | 369.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
